FCA 2013 Patterns Set 2014 Trends

Top Health Issues of 2015

Posted on 29. Jan, 2015 by .

According to a recent report released by PwC’s Health Research Institute, the $2.8 trillion US healthcare industry is undergoing profound transformation. The report outlined ten top health issues for 2015 including the fact that consumers are bearing more of the cost of their own care as well as making more decisions, and manufacturers are gearing [...]

Continue Reading

China’s Imports Growing Larger and Larger

Posted on 12. Jan, 2015 by .

Margaret A. Hamburg, M.D., the Commissioner of the Food and Drug Administration, recently returned from a trip to China, and has some interesting facts and figures to report: Of the 200 countries that export their products to the United States, China ranks first in exports (in dollar value) to our nation. China is the sixth [...]

Continue Reading

Good Documentation Practices – The Value of Categorization

Posted on 05. Jan, 2015 by .

For anyone who has written documentation, the act of researching and writing instructions is really just the first step in the process. As a former documentation specialist, I learned the hard way that organizing documents is as important as crafting the documents. This was confirmed in our Good Documentation Practices webinar last month, featuring ex-FDA [...]

Continue Reading

What Will Happen with Affordable Care Act?

Posted on 18. Dec, 2014 by .

With the recent sweeping victory of the Republicans, it seems that a natural target in the political landscape will be to attempt to remove the Affordable Care Act or what they deem as “Obamacare.” What does this mean within the industry? Well, let’s look at what might be the future of Obamacare. First, the Republicans [...]

Continue Reading

Generic Drug Prices on the Rise

Posted on 09. Dec, 2014 by .

According to Vermont Senator, Bernie Sanders (I-VT), the prices of more than 1,200 generic medications increased an average of 448 percent between July 2013 and July 2014. This does not seem logical to the law maker as generic drug manufacturing companies don’t have the high investment in research and development and marketing that impact other [...]

Continue Reading

Five Quick Information Pieces about Ebola

Posted on 25. Nov, 2014 by .

Ebola is all over the news with cases now being reported in New York.  The medical community is working hard to combat Ebola along with political interventions and policy changes such as restricted flights and quarantining of visitors returning from certain locations. Here is a quick list of five pieces of information about Ebola. 1: [...]

Continue Reading

Medical Device Companies: Making the News for All the Wrong Reasons

Posted on 25. Nov, 2014 by .

Recently, several Medical Device companies have been making the news for some record settlements, recalls and court cases: Stryker, the artificial hip implant company, announced that it has reached a settlement of thousands of lawsuits related to those who claimed to be injured by a hip replacement in which the replacement’s ball and cup components [...]

Continue Reading

Using Evaluation to Craft a Better Compliance Training Program

Using Evaluation to Craft a Better Compliance Training Program

Posted on 19. Nov, 2014 by .

Many groups within organizations look to performance measures to determine the impact of an initiative. Sales teams look at sales numbers, number of calls and volume of product sold. Manufacturing organizations look at the quality of goods produced, number of goods produced and safety of employees during the production process. It only makes sense that [...]

Continue Reading